CompletedNCT00156065
Asenapine Using Haloperidol for Schizophrenia
This study is completed in Global. It is testing asenapine Using Haloperidol for Schizophrenia.
In GlobalSchizophreniaOtherOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00156091
Asenapine Using Olanzapine for Schizophrenia
This study is completed in Global. It is testing asenapine Using Olanzapine for Schizophrenia.
In GlobalSchizophreniaOtherOver 18 Years
CompletedNCT05825235
Long-term Efficacy of Pramipexole in Anhedonic Depression
This study is completed. It focuses on depression and currently lists study information in Sweden.
In LundDepressionOtherFrom 18 Years to 75 Years
CompletedNCT01614912
Long-term Extension Study of SM-13496 (Lurasidone HCl) in people with Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in Japan, Malaysia, South Korea, and Taiwan.
Multiple locations, including Tokyo, EtcSchizophreniaOtherFrom 18 Years to 74 Years
CompletedNCT01142596
Long-term Extension study of Asenapine in Subjects With Schizophrenia (Study P06125)
This study is completed. It focuses on schizophrenia and currently lists study information in Global.
In GlobalSchizophreniaOtherFrom 20 Years to 64 Years
WithdrawnNCT06733558
Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT
This study has public registry information. It focuses on depression and currently lists study information in the United States.
In AlbuquerqueDepression, BipolarityOtherFrom 18 Years to 80 Years
CompletedNCT01059539
Long-term Safety and Tolerability of Cariprazine for Bipolarity I
This study is completed. It focuses on bipolarity and currently lists study information in Hungary, Poland, Spain, and the United States.
Multiple locations, including SpringdaleBipolarityOtherFrom 18 Years to 65 Years
Enrolling By InvitationNCT04987229
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
This study is enrolling by invitation. It focuses on schizophrenia and currently lists participation information in Argentina, Brazil, Colombia, Mexico, and the United States.
Multiple locations, including DothanSchizophrenia, BipolarityOtherFrom 10 Years to 17 Years
CompletedNCT01395992
Long-Term Safety Extension study of Asenapine in Bipolarity type I Participants Who Completed Protocol P05691 (P05692)
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In AustinBipolarityOtherOver 18 Years
CompletedNCT02168127
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
This study is completed. It focuses on ADHD and currently lists study information in Canada and the United States.
Multiple locations, including Los AngelesADHDOtherOver 12 Years
TerminatedNCT04708834
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
This study has public registry information. It focuses on mental health and currently lists study information in Canada, Italy, the Netherlands, Spain, the United Kingdom, and the United States.
Multiple locations, including ChandlerMental healthOtherFrom 18 Years to 65 Years
CompletedNCT06423781
Safety study of BHV-7000 in depression
This study is completed in the United States. It is testing BHV-7000 for depression.
Multiple locations, including ChandlerDepressionOtherFrom 18 Years to 75 Years